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Abstract
This purpose of the study is to examine the difference in the health-related quality of life (HRQOL) between individuals who suffer from physician-diagnosed arthritis compared with
individuals who do not suffer from physician-diagnosed arthritis in a population of university
students, faculty, and staff. The study sampled from a population of students, faculty, and staff
at the University of Central Florida. Through the implantation of a cross-sectional ecological
design, differences between the two groups were measured with a survey that measures healthrelated quality of life, such as the 36-Item Short Form Health Survey (SF-36). The SF-36
questionnaire was distributed to subjects through a campus-wide email system and was
administered through Qualtrics, an online survey program. Literature suggests lower SF-36
scores for individuals suffering from arthritis, but is lacking in investigating the effect of arthritis
on college-aged students, particularly within the 18-24 age group. The study aims to close this
gap in the literature. SPSS software was used to analyze results through tests of association, like
ANOVA, which measured differences in the SF-36 scores of subjects with physician-diagnosed
arthritis and subjects without physician-diagnosed arthritis. Results showed a significant
difference in the HR-QOL scores between individuals with arthritis and individuals without
arthritis, as well as age, gender, ethnicity, and the presence of joint pain.
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Background
Introduction
Arthritis is a general term for any of the more than 100 pathologic conditions affecting
the joints and surrounding tissues that cause symptoms such as pain, stiffness, and inflammation
(Arthritis in General, 2016). Two of the most common types of arthritis are osteoarthritis, a
progressive, non-inflammatory joint disorder resulting in progressive loss of articular cartilage
more prevalent in older adults, and rheumatoid arthritis, an autoimmune disease, systematic in
nature, causing widespread joint inflammation (Copstead & Banasik, 2013).
Osteoarthritis is a noninflammatory joint disorder characterized by progressive damage to
diarthrodial joints most prevalent in adults over the age of 70 (Copstead & Banasik, 2013). The
etiology of osteoarthritis is a combination of lifestyle factors, such as obesity or long-term insult
to the joints affected and genetic factors, such as congenital disorders causing abnormal joint
movement (Copstead & Banasik, 2013). The disease results in the development of several
pathologic changes, starting with the breakdown of hyaline cartilage at the surface of bones,
which leads to the structural deterioration of joints through the growth of osteophytes and
thickening of subchondral bone (Loeser, Goldring, Scanzello & Goldring, 2012). These
manifestations, in addition to damaging effects in the surrounding tissue, are responsible for
causing pain, discomfort, and reduced range of motion in those who are affected (Loeser et al.,
2012).
Since osteoarthritis is degenerative and progresses over time, the primary goal of
treatment is to reduce pain and maintain normal range of motion (Michael, Schlüter-Brust &
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Eysel, 2010). This is accomplished primarily through physiotherapy, orthopedic aids,
pharmacotherapy, and in severe cases, surgery (Michael et al., 2010). In a randomized
controlled trial of 43 adults diagnosed with osteoarthritis, a regime of manual therapy proved to
be significantly beneficial in decreasing the amount of pain and improving physical mobility for
patients (Pollard, Ward, Hoskins & Hardy, 2008). Additionally, the administration of antiinflammatory medications such as non-steroidal anti-inflammatory drugs (NSAIDs),
corticosteroids, and COX-inhibitors are also proven (Michael et al., 2010). The antiinflammatory mechanisms of these drugs alleviate the pain associated with joint damage and
allow patients to function at a higher level, although each class of drugs has considerable side
effects of varying severity (Michael, et al., 2010) and (Ong, Lirk, Tan & Seymour, 2007).
Unlike osteoarthritis, which is progressive and degenerative in nature, rheumatoid
arthritis is an autoimmune disease, and its etiology is based on a wide variety of factors, with
genetic predisposition playing a major role (Choy, 2012). More specifically, certain alleles of
the HLA-DRB1 gene have been associated with the development of RA in patients diagnosed
with the disease (Lechler & Warrens, 2000). The disease is characterized by the activation of
immune cells (B cells and T cells) via an antigen trigger, which allows B cells to recruit
additional immune cells, eventually activating the complement system and the production of
cytokines, thus causing widespread inflammation throughout the body (Choy, 2012). Due to the
autoimmune nature of rheumatoid arthritis, it is a systemic disease that can cause damage almost
anywhere in the body, including, but not limited to the joints, the heart, the lungs, and the eyes
(Choy, 2012).
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Due to the autoimmune nature of rheumatoid arthritis, the primary treatment of the
disease is to slow the progression of damage in order to prevent permanent, debilitating effects
associated with untreated RA. This is accomplished through the use of disease-modifying
antirheumatic drugs (DMARDs), such as methotrexate, and biologic agents, such as tumor
necrosis factor (TNF) inhibitors. Per recommendations from both the European League against
Rheumatism (EULAR) and the American College of Rheumatology (ACR), the use of diseasemodifying antirheumatic drugs (DMARDs), such as methotrexate and TNF-inhibitors, such as
adalimumab, etanercept, and infliximab, are particularly effective at preventing the pathologic
manifestations of RA that are associated with long-term damage (Smolen et al., 2013; Singh et
al., 2016).
Reducing the symptoms associated with widespread inflammation in order to maintain a
normal lifestyle is also a major goal of RA treatment. Whereas DMARDs and TNF-inhibitors
affect the pathophysiology processes of RA, medications such as aspirin and non-steroidal antiinflammatory drugs (NSAIDs) are aimed at reducing inflammation and pain treat the symptoms
of RA for a more immediate effect, albeit with varied levels of success (Conaghan, 2012).
For most, if not all, types of arthritis, the chief complaint of patients tends to be high levels of
pain, which subsequently lead to decreased levels of physical functioning (Pollard, Choy &
Scott, 2005). Additionally, arthritis is classified as a chronic disease, and per the World Health
Organization (WHO), chronic diseases, such as osteoarthritis and rheumatoid arthritis, tend to
leave patients with some level of impairment, disability, and handicap (Pollard et al., 2005).
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Literature Review
One way to quantify the extent of arthritis on an individual’s health is by measuring
health-related quality of life, or HR-QOL (Sajid, Tonsi & Baig, 2008). An individual’s HR-QOL
is commonly measured through a validated, self-reported survey, such as the 36-Item Short Form
Health Survey (SF-36), which can be used for a wide variety of conditions to assess general
health (Pollard et al., 2005), or the Health Assessment Questionnaire (HAQ), which is similar in
nature, among many others (Hurst, Kind, Ruta, Hunter & Stubbings, 1997). Each of these
surveys differ slightly in the variables measured, but all have the common goal of assessing the
effects of chronic disease on one’s overall well-being, or HR-QOL. Additionally, since each
HR-QOL survey assesses different aspects of health, it can be difficult to compare studies based
solely on data, meaning all survey results used to draw conclusions in research must be
completely understood before being used as the basis for future studies (Hurst et al., 1997).
The use of surveys to measure HR-QOL allows researchers to quantify how a disease is
affecting an individual in several categories, such as level of pain, ability to function physically,
overall mental health, etc. (Hurst et al., 1997). Based on previous studies, there is considerable
evidence that individuals diagnosed with arthritis have significant differences in HR-QOL
scores.
Most studies in the literature focus on the impacts of either OA or RA on subjects’ HRQOL, but a cross-sectional study by the Australian researchers Hunter and Riordan utilized a
generalized questionnaire to determine the effect of many different types of arthritis, including
OA and RA, on HR-QOL (Hunter & Riordan, 2014). The study found that patients with arthritis
scored considerably lower on the EQ-5D, which is a European-based HR-QOL scoring system,
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than those in the healthy population (Hunter & Riordan, 2014). In fact, arthritis patients
measured in the study scored lower on this HR-QOL scale than patients in comparable studies
with diseases such as breast cancer, type II diabetes, anxiety disorders, and severe cardiac
disease (Hunter & Riordan, 2014), suggesting that arthritis has a considerably negative impact on
the lives of those affected.
The Hunter and Riordan study was also one of the few in the literature to have sufficient
data for patients in all age groups, and suggested several important points. For one, patients in
the 18-24 age group showed a much higher level of concern (24%) in regard to the impact of
arthritis on the “social aspects of life,” compared to the entire sample average, which was only
5% (Hunter and Riordan, 2014). This may be a significant finding about arthritis in younger,
college-aged populations, but further data regarding the impact of arthritis on younger patients,
particularly those within the 18-24 age group, is sparse, and does not exist in large quantities.
In a cohort study investigating chronic hip and knee complaints, there was a significant
decrease in the HRQL in patients with chronic complaints in the hip and knee when compared to
patients without these complaints (van der Waal, Terwee, van der Windt, Bouter & Dekker,
2005). In fact, patients with chronic hip and knee complaints were found to have HRQL scores
(in the category of physical functioning) of up to 2.9 standard deviations below those without the
same complaints, demonstrating that symptoms similar in nature to osteoarthritis can be
detrimental to the quality of life (van der Waal et al., 2005). These findings are bolstered by
another study, which found significant associations between those with lower limb osteoarthritis
and decreased HR-QOL, although in this particular study, the negative impact of OA was more
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prevalent in females, which follows common patterns associated with arthritis (Rosemann et al.,
2007).
Similar relationships exist in those who suffer from rheumatoid arthritis, with the
systemic nature of RA causing significantly decreased HRQL in many studies, due to pain,
inflammation, and additional, non joint-related symptoms (Choy, 2012).
In an long-term cohort study of RA patients, increasing age was correlated with increased
erythrocyte sedimentation rate (ESR), which is both a blood test measuring inflammation in the
body and a biomarker in the diagnosis of RA (Radovits, Fransen, van Riel & Laan 2008). While
this alone is not enough to make a determination about the impact of RA over long periods of
time, it does indicate that levels of inflammation increase in older adults with RA, suggesting the
severity of RA could be higher in older adults in comparison to younger adults. Additionally, it
could suggest the impact of RA on younger adults is associated with a less severe course of RA
and less comorbidities, meaning higher levels of HR-QOL, but these inferences cannot be proven
from the data presented in this study (Radovits et al., 2008).
There is also evidence to suggest that patients with RA score lower on both the Physical
Functioning (PCS) and Mental Functioning (MCS) scales in the SF-36 than patients with other
inflammatory arthritis conditions, such as ankylosing spondylitis and psoriatic arthritis (Salaffi,
Carotti, Gasparini, Intorcia & Grassi, 2009).
One major limitation with many studies investigating the HR-QOL in individuals with
both osteoarthritis and rheumatoid arthritis is the age of subjects included in such studies. Many
studies investigating arthritis and HR-QOL have samples with the average age of subjects well
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into their 50s. Below is a chart outlining the prevalence of self-reported physician-diagnosed
arthritis in the U.S. population (Helmick et al., 2008).
Table 1: Prevalence of Self-Reported Physician-Diagnosed Arthritis

Age Group

Total Population

Doctor-Diagnosed Arthritis

18-44

110,318,000

8,700,000 (7.89%)

45-64

70,019,000

20,500,000 (29.3%)

65+

34,435,000

17,200,000 (49.9%)

Total

214,772,000

46,400,000 (21.6%)

Per this study by Helmick, et al., the prevalence of arthritis is higher in older populations
versus younger populations, thus accounting for the majority of arthritis studies sampling
primarily older individuals. But, in studies that do include younger individuals, evident
differences in the effects of arthritis have been observed, suggesting that the disease affects
younger adults differently than older adults. Given the limited amount of data about younger
people, particularly those of college age (18-24), there is a lack of knowledge about the specific
effects of arthritis on individuals of this age group in regard to HR-QOL, and more research must
be done.
With rheumatoid arthritis, many previous studies have shown a correlation between the
presence of disease and lowered mental health scores on HR-QOL surveys, such as the SF-36.
In a study done by Salaffi et al., the mean SF-36 MCS (mental functioning) score for subjects
aged 18-34 in the control group was 47.7 +/- 6.9, whereas the mean SF-36 MCS score for those
in the RA group was 40.6 +/- 9.9, showing a significant decrease in the mental health of RA
patients compared to subjects in the control group (Salaffi, et al., 2009).
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There are many other studies in the literature suggesting associations between mental
health disorders, such as depression and anxiety, and arthritis. One study with data based on
self-reported answers estimated that about 30% of arthritis patients suffer from anxiety and
17.5% suffer from depression, both of which are significantly higher than the prevalence of those
in the general population (Murphy, Sacks, Brady, Hootman & Chapman, 2012). In another
study, it was found that major depression is prevalent in patients with rheumatoid arthritis at a
rate of approximately 16.8%, which is much higher than the rate in the general population (4.1%)
(Matcham, Rayner, Steer & Hotopf, 2013; Waraich, Goldner, Somers & Hsu, 2004).
This, combined with the fact that mental health disorders, such as anxiety and depression
are becoming increasingly prevalent on college campuses, raises questions about the impacts of
arthritis on college students (Beiter et al., 2015; Ibrahim, Kelly, Adams & Glazebrook, 2013).
The lack of data for younger arthritis patients, particularly those within the 18-24 age
group, is responsible for the knowledge gap with respect to arthritis and HR-QOL. A study
investigating the relationship between young adults with arthritis and employment showed that
there are some differences between employment statistics of subjects with arthritis versus
subjects without arthritis, but many of the findings were not statistically significant (Jetha, 2015).
In fact, one of the main findings from the Jetha study was the determination that there were not
enough studies on impacts of arthritis on young adults to make significant inferences (Jetha,
2015).
Without sufficient literature on this relationship, future studies in this area must be of the
highest importance. This study focused on the difference in HR-QOL of subjects with arthritis
and subjects without arthritis on a university campus, therefore attempting to determine if there
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is a significant difference in the HR-QOL scores. The researchers in this study attempted to find
statistically significant data about the impact of arthritis on subjects at a university campus, thus
adding knowledge to an area where there is a serious gap.
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Methodology
Study Design
The study design is a cross-sectional ecological study. The aim of the research was to
determine if there is a statistically significant difference in the health-related quality of life (HRQOL) of those with arthritis as compared to those without arthritis. This established two groups
of subjects: subjects with a self-reported physician-diagnosed arthritis condition and subjects
without a self-reported physician-diagnosed arthritis condition. The research aimed to answer
two questions: Is there a significantly significant difference in the health-related quality of life
(HR-QOL) of those with self-reported doctor-diagnosed arthritis when compared to those
without self-reported doctor-diagnosed arthritis? And, among which demographic group is the
prevalence of arthritis the highest?
Sampling
The University of Central Florida currently has 63,016 students and a total of 11,642
employees and faculty. In order to make sampling easier, the survey will be sent out to all
students, employees, and faculty within the College of Health and Public Affairs through a
college-wide email system. Those who complete the informed consent and meet
inclusion/exclusion criteria will be permitted to take the full survey and to participate in the
study. Completion, and submission, of the survey is all that is required of study subjects.
Inclusionary and Exclusionary Criteria
Individuals who are at least 18 years of age and are a student, faculty member, or staff
member at the University of Central Florida were included in the study. The survey asked three
questions about subjects’ medical history in reference to arthritis, but these questions were not
10

for inclusionary and exclusionary criteria, but rather for the purpose of creating two groups of
subjects on the basis of self-reported physician-diagnosed arthritis.
Instrumentation
Participants were initially given a nine question screening survey. Screening questions
have been developed by the researcher and were used for the sole purpose of determining
eligibility, demographic information, and diagnostic history with respect to arthritis. The last
three questions of the screening survey asked subjects about any joint pain within the last few
months, if they have ever been diagnosed with arthritis by a doctor, and if they have been
diagnosed with arthritis, with which type. These questions were derived from the Adult
Conditions category of the 2015 National Health Interview Survey (NHIS) (2015 NHIS
Questionnaire – Sample Adult (Adult Identification), 2016).
If subjects were deemed eligible to participate, they were then given the 36-Item Short
Form Survey (SF-36), which is a professionally developed and validated quality of life survey.
The SF-36 measures an individual’s quality of life through the following scales: physical
functioning, role limitations due to physical health, role limitations due to emotional problems,
energy/fatigue, emotional well-being, social functioning, pain, and general health (Salaffi, et al.,
2009). Additionally, the SF-36 allows researchers to calculate summary component scores for
both physical functioning (PCS) and mental functioning (MCS) (Salaffi, et al., 2009). The SF-36
has been validated in previous studies for measuring the HR-QOL in patients with both
osteoarthritis and rheumatoid arthritis and has proven to be a “psychometrically robust”
instrument (ten Klooster, et al., 2013) and (Kosinski, Keller, Hatoum, Kong & Ware, 1999).
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The SF-36 was the primary instrument of this study and was used to quantify the
differences between arthritis patients and non-arthritis patients in the study. Each of the
questionnaire’s 36 questions relate to one of the eight scales and the two summary component
scores (PCS and MCS) and these values will be used for comparisons between groups. For each
of the eight scales, the highest score for each question is 100 and the lowest score is 0, meaning a
scale score of 100 would be the “highest” level for quality of life and a scale score of 0 would be
the “lowest” quality of life scale (36-Item Short Form Survey (SF-36) Scoring Instructions).
Therefore, higher PCS and MCS scores on the SF-36 would indicate a “higher” level for quality
of life, and lower PCS and MCS scores on the SF-36 would indicate a “lower” level for quality
of life.
Figure 1: Scales and Constructs of the SF-36
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Qualtrics is a web-based survey tool used by researchers at the University of Central
Florida and was used to build the questionnaire and allowed for easy distribution of the
questionnaire to UCF students, faculty, and staff through the campus-wide email system.
SPSS software was used to analyze data collected from questionnaire responses and to
perform several statistical tests on the data in order to determine significance. Means and
standard deviations for the two component summary scores (PCS and MCS scores) the SF-36
measures were calculated for both groups and compared to each other through ANOVA.
ANOVA was also performed to determine differences between demographic groups studied as
well.
Hypotheses
• Null Hypothesis (Ho): There will be no association between the PCS and MCS scores on
the SF-36 questionnaire between subjects with doctor-diagnosed arthritis and subjects
without doctor-diagnosed arthritis.
•

Experimental Hypothesis (H1): PCS and MCS scores on the SF-36 questionnaire for
subjects with doctor-diagnosed arthritis will be significantly lower than the PCS and
MCS scores for subjects without doctor-diagnosed arthritis.

•

Alternative Hypotheses:
o H2: PCS and MCS scores on the SF-36 questionnaire for subjects who report
having doctor-diagnosed rheumatoid arthritis will be significantly lower than
subjects who report having any other type of doctor-diagnosed arthritis.
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o H3: PCS and MCS scores on the SF-36 questionnaire for faculty and staff who
report having doctor-diagnosed arthritis will be significantly lower than students
who report having doctor-diagnosed arthritis.
o H4: The Mental Functioning Score (MCS) for all subjects reporting doctordiagnosed arthritis will be significantly lower than the MCS for all subjects who
do not report having doctor-diagnosed arthritis.
o H5: The Physical Functioning Score (PCS) for all subjects reporting doctordiagnosed arthritis will be significantly lower than the PCS for all subjects who
do not report having doctor-diagnosed arthritis.
Ethical Considerations
The study uses human subjects and has gone through the appropriate ethical review
with the Institutional Review Board (IRB) at the University of Central Florida. The study will
respect the autonomy of all subjects and will uphold the ethical principles of beneficence and
nonmaleficence. Since the questionnaire was administered to all subjects through a personal
computer, the risk of physical harm is very small and the risk of mental or emotional harm is also
minimal. Nevertheless, anyone participating in the questionnaire had the ability to withdraw at
any time, and were not part of the study until they answered all the questions and electronically
submitted the survey through the Qualtrics system.
Per IRB protocol, both the privacy and confidentiality of subjects were protected, and this
will not have any negative effects on the collection or analysis of data for the purposes of the
study. No identifying information was asked of subjects when completing the questionnaire, and
the only personal questions being asked will pertain to age, demographics, status at the
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University of Central Florida, and several questions about each subjects’ medical history as it
pertains to arthritis. Additionally, all data collected from the questionnaires was stored on
password-protected computers in the possession of the researchers.
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Results
Review of Study Participants
A total of 333 participants submitted questionnaires through Qualtrics, and 35 of these
responses were discarded because they were incomplete, so 298 responses were used for analysis
of the study. Demographics-wise, the largest age group was the 18-22 group, with 46.6% (n =
139) respondents, followed by the 23-27 group, with 19.1% (n = 57), making the majority of
study participants between the ages of 18 and 27 (Table 2). Females outnumbered males by a
large margin, 86.1% (n = 254) and 13.6% (n = 40), respectively (Table 2). In terms of ethnicity,
white participants were the majority, with 61.4% (n = 183), followed by Hispanics/Latinos at
16.4% (n = 49) (Table 2). In regard to status at UCF, the majority of respondents were
undergraduate students, with 67.4% (n = 201), followed by graduate students with 20.8% (n =
62) (Table 2). Combined, faculty and staff made up 11.7% (n = 35) of the study population
(Table 2). Among the undergraduate students, juniors and seniors were a large majority, with
81.1% (n = 163) of the undergraduate sample (Table 2). Finally, of the 298 study participants,
54.5% (n = 158) reported pain, aching, or stiffness in or around a joint during the past few
months (Table 2).
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Table 2: Demographic Data for Study Participants
n

%

Mean PCS

Mean MCS

AGE
18-22
23-27
28-32
33-39
40-49
50-59
60+

139
57
24
27
24
18
9

46.6%
19.1%
8.1%
9.1%
8.1%
6.0%
3.0%

81.25
81.00
74.87
74.70
72.45
66.84
68.33

65.54
64.27
66.54
63.70
68.37
71.08
71.78

GENDER
Male
Female

40
254

13.6%
86.1%

78.08
78.32

68.71
65.53

ETHNICITY
Asian
Black or African American
Native Hawaiian or Pacific Islander
White
Hispanic or Latino
Biracial or Multiracial

14
34
1
183
49
16

4.7%
11.4%
0.3%
61.4%
16.4%
5.4%

71.12
83.93
20.63
78.33
77.33
74.57

60.90
72.11
55.13
65.68
65.31
65.13

STATUS
Faculty
Staff
Graduate/Professional Student
Undergraduate Student

18
17
62
201

6.0%
5.7%
20.8%
67.4%

80.45
69.74
79.88
78.09

74.36
69.64
65.11
65.17

CLASSIFICATION (among
undergraduate students)
Freshman
Sophomore
Junior
Senior

13
25
78
85

6.5%
12.4%
38.8%
42.3%

79.95
76.78
77.40
78.82

67.83
58.95
65.01
66.72

JOINT STIFFNESS
Yes
No

158
132

54.5%
45.5%

73.39
84.28

65.71
67.35

PHYSICIAN-DIAGNOSED ARTHRITIS
Yes
No
Don’t Know

50
244
4

16.8%
81.9%
1.3%

66.50
80.91
53.44

66.96
65.82
62.63

TYPE OF ARTHRITIS (among physiciandiagnosed arthritis)
Rheumatoid Arthritis
Osteoarthrits
Other

6
27
17

12.0%
54.0%
34.0%

67.60
65.97
66.95

63.59
71.38
61.13
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Of the 298 study participants, 16.8% (n = 50) reported having physician-diagnosed
arthritis (Figure 2). When looking at age as a variable, the age groups with the most participants
reporting arthritis were the 18-22 age group and the 50-59 age group, with 24.0% (n = 12) of the
total arthritis participants found in each. In terms of gender, 82.0% (n = 41) of the participants
reporting arthritis were female, and 16.0% (n = 8) were male. Of the six different ethnicities
available in the survey, 74.0% (n = 37) were white and 18.0% (n = 9) were African-American or
black. With UCF Status as a variable, 44.0% (n = 22) of participants reporting arthritis were
undergraduate students, 22.0% (n = 11) were graduate or professional students, 20.0% (n = 10)
were staff, and 14.0% (n = 7) were faculty members. Of the undergraduate students reporting
arthritis, there were ten seniors, eight juniors, two sophomores, and two freshmen.
Of the participants reporting arthritis, 96% (n = 47) reported suffering from joint pain,
aching, or stiffness over the past few months.
Of the 50 reporting physician-diagnosed arthritis, 12.0% (n = 6) reported rheumatoid
arthritis, 54% (n = 27) reported osteoarthritis, and 34% (n = 17) reported “other” and had the
option of directly inputting their diagnosis in a text box. Of the 17 reporting “other”, 16
provided further explanations (four were unable to recall the type, five reported “juvenile”, and
the remaining seven were inconclusive as to which type).
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Figure 2: Study Participants with and without Arthritis

Total study
participants
100%
(n = 298)

Total reporting physiciandiagnosed arthritis
16.8%
(n = 50)

Rheumatoid arthritis
(RA)
12.0%
(n = 6)

Osteoarthritis
(OA)
54.0%
(n = 27)

No physician-diagnosed
arthritis
81.9%
(n = 244)

“Other”
34.0%
(n = 17)

19

Table 3: Demographic Data for Participants with Arthritis
n

%1

% of total
demo pop.2

Mean PCS

Mean MCS

AGE
18-22
23-27
28-32
33-39
40-49
50-59
60+

12
3
2
6
9
12
6

24.0%
6.0%
4.0%
12.0%
18.0%
24.0%
12.0%

8.6%
5.3%
8.3%
22.2%
37.5%
66.7%
66.7%

70.26
55.42
58.13
57.81
64.03
69.69
73.33

61.81
46.00
67.60
61.57
64.54
74.36
81.72

GENDER
Male
Female

8
41

16.0%
82.0%

20.0%
16.1%

66.56
66.72

65.26
66.47

ETHNICITY
Asian
Black or African-American
Native Hawaiian or Pacific Islander
White
Hispanic or Latino
Biracial/Multiracial

0
9
0
37
3
1

0.0%
18.0%
0.0%
74.0%
6.0%
2.0%

0.0%
26.5%
0.0%
20.2%
6.1%
6.3%

N/A
75.76
N/A
64.76
52.71
88.75

N/A
70.33
N/A
66.37
56.81
88.75

STATUS
Faculty
Staff
Graduate/Professional Student
Undergraduate Student

7
10
11
22

14.0%
20.0%
22.0%
44.0%

38.9%
58.8%
17.7%
10.9%

79.91
68.56
68.09
60.51

78.21
74.34
63.90
61.55

CLASSIFICATION
Freshman
Sophomore
Junior
Senior

2
2
8
10

4.0%
4.0%
16.0%
20.0%

15.4%
8.0%
10.3%
11.8%

69.06
77.81
38.90
72.63

76.52
44.60
54.56
67.54

Statistical Analysis
Upon completion of data collection, data was exported from Qualtrics into the Statistical
Package for the Social Sciences (SPSS). Variable names were assigned to each of the nine
questions in the screener survey (Appendix I) and proper scoring values were assigned to each of
1
2

Proportion of total arthritis population
Proportion of arthritis participants per demographic group
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the 36 questions in the SF-36 using the “36-Item Short Form Survey (SF-36) Scoring
Instructions.” Scores for each of the eight categories (physical functioning, general health,
bodily pain, role physical, vitality, social functioning, role emotional, and mental functioning)
were calculated and used to calculate the PCS and MCS scores that will be used for the majority
of analysis.
Initially, frequencies were calculated for each of the demographic groups using the
descriptive statistics tool in SPSS. Means and standard deviations for both PCS and MCS scores
were then calculated for each demographic group.
One-way Analysis of Variance (ANOVA) tests were used to test for associations between
the dependent variables (PCS and MCS) and each of the demographic and medical history
questions found in the screener survey (Appendix I). The first set of ANOVAs were computed
to test for significant differences between mean PCS scores and age, gender, ethnicity, UCF
status, UCF classification, joint pain, presence of physician-diagnosed arthritis in the study
population (n = 298) and between mean MCS scores and age, gender, ethnicity, UCF status,
UCF classification, joint pain, presence of physician-diagnosed arthritis in the study population
(n = 298). For each of these tests, a 95% confidence interval was used. Below are the results of
each ANOVA ran:
1. A one-way ANOVA was computed to compare the mean PCS scores of study
participants in each of the seven age groups. A significant difference was found
between each of the age groups (p = 0.027) (Figure 15).
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2. A one-way ANOVA was computed to compare the mean MCS scores of study
participants in each of the seven age groups, and the ANOVA was not significant (p >
0.05).
3. A one-way ANOVA was computed to compare the mean PCS scores of male and
female study participants. A significant difference was found between males and
females (p = 0.025) (Figure 16).
4. A one-way ANOVA was computed to compare the mean MCS scores of male and
female study participants, and the ANOVA was not significant (p > 0.05).
5. A one-way ANOVA was computed to compare the mean PCS scores of study
participants in each of the six ethnicities. A significant difference was found between
the ethnicities (p = 0.034) (Figure 17).
6. A one-way ANOVA was computed to compare the mean MCS scores of study
participants in each of the six ethnicities, and the ANOVA was not significant (p >
0.05).
7. A one-way ANOVA was computed to compare the mean PCS scores of study
participants in each of the four UCF statuses, and the ANOVA was not significant (p
> 0.05).
8. A one-way ANOVA was computed to compare the mean MCS scores of study
participants in each of the four UCF statuses, and the ANOVA was not significant (p
> 0.05).
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9. A one-way ANOVA was computed to compare the mean PCS scores of study
participants in each of the four UCF classifications, and the ANOVA was not
significant (p > 0.05).
10. A one-way ANOVA was computed to compare the mean MCS scores of study
participants in each of the four UCF classifications, and the ANOVA was not
significant (p > 0.05).
11. A one-way ANOVA was computed to compare the mean PCS scores of study
participants either reporting joint pain or not reporting joint pain. A significant
difference was found among participants reporting joint pain and participants not
reporting joint pain (p < 0.000) (Figure 18).
12. A one-way ANOVA was computed to compare the mean MCS scores of study
participants either reporting joint pain or not reporting joint pain, and the ANOVA
was not significant (p > 0.05).
13. A one-way ANOVA was computed to compare the mean PCS scores of study
participants either reporting physician-diagnosed arthritis or not reporting physiciandiagnosed arthritis. A significant difference was found among participants reporting
arthritis and participants not reporting arthritis (p < 0.000) (Figure 19).
14. A one-way ANOVA was computed to compare the mean MCS scores of study
participants either reporting physician-diagnosed arthritis or not reporting physiciandiagnosed arthritis, and the ANOVA was not significant (p > 0.05).
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Table 4: ANOVA between PCS scores and
the age variable for the study population

ANOVA
Sum of Squares
PCS

Between Groups

df

Mean Square

6331.566

6

1055.261

Within Groups

127132.105

291

436.880

Total

133463.671

297

F
2.415

Sig.
.027

Table 5: ANOVA between PCS scores and
the gender variable for the study population

ANOVA
Sum of Squares
PCS

Between Groups

df

Mean Square

3315.597

2

1657.798

Within Groups

129164.533

292

442.344

Total

132480.130

294

F
3.748

Sig.
.025

Table 6: ANOVA between PCS scores and
the ethnicity variable among the study population

ANOVA
Sum of Squares
PCS

Between Groups

df

Mean Square

5383.168

5

1076.634

Within Groups

127923.779

291

439.601

Total

133306.947

296

F
2.449

Sig.
.034

Table 7: ANOVA between PCS scores and
the joint pain variable among the study population

ANOVA
Sum of Squares
PCS

Between Groups

df

Mean Square

8528.021

1

8528.021

Within Groups

118550.816

288

411.635

Total

127078.838

289

24

F
20.717

Sig.
.000

Table 8: ANOVA between PCS scores and
the physician-diagnosed arthritis variable
for the study population

ANOVA
Sum of Squares
PCS

Between Groups

df

Mean Square

11093.488

2

5546.744

Within Groups

122370.183

295

414.814

Total

133463.671

297

F
13.372

Sig.
.000

The second set of ANOVAs were run to test for differences between mean PCS scores
and age, gender, ethnicity, UCF status, UCF classification, joint pain, and type of arthritis in the
population of participants with physician-diagnosed arthritis (n = 50) and between mean MCS
scores and age, gender, ethnicity, UCF status, UCF classification, joint pain, and type of arthritis
in the population of participants with physician-diagnosed arthritis (n = 50).
1. A one-way ANOVA was computed to compare the mean PCS scores of study
participants with physician-diagnosed arthritis in each of the seven age groups,
and the ANOVA was not significant (p > 0.05).
2. A one-way ANOVA was computed to compare the mean MCS scores of study
participants with physician-diagnosed arthritis in each of the seven age groups,
and the ANOVA was not significant (p > 0.05).
3. A one-way ANOVA was computed to compare the mean PCS scores for male and
female study participants with physician-diagnosed arthritis, and the ANOVA was
not significant (p > 0.05).
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4. A one-way ANOVA was computed to compare the mean MCS scores for male
and female study participants with physician-diagnosed arthritis, and the ANOVA
was not significant (p > 0.05).
5. A one-way ANOVA was computed to compare the mean PCS scores of study
participants with physician-diagnosed arthritis in each of the six ethnicities, and
the ANOVA was not significant (p > 0.05).
6. A one-way ANOVA was computed to compare the mean MCS scores of study
participants with physician-diagnosed arthritis in each of the six ethnicities, and
the ANOVA was not significant (p > 0.05).
7. A one-way ANOVA was computed to compare the mean PCS scores of study
participants with physician-diagnosed arthritis in each of the four UCF statuses,
and the ANOVA was not significant (p > 0.05).
8. A one-way ANOVA was computed to compare the mean MCS scores of study
participants with physician-diagnosed arthritis in each of the four UCF statuses,
and the ANOVA was not significant (p > 0.05).
9. A one-way ANOVA was computed to compare the mean PCS scores of study
participants with physician-diagnosed arthritis in each of the four UCF
classifications. A significant difference was found among UCF classifications in
the sample of participants reporting physician-diagnosed arthritis (p = 0.021)
(Figure 20).
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10. A one-way ANOVA was computed to compare the mean MCS scores of study
participants with physician-diagnosed arthritis in each of the four UCF
classifications, and the ANOVA was not significant (p > 0.05).
11. A one-way ANOVA was computed to compare the mean PCS scores of study
participants with physician-diagnosed arthritis in each of the three categories of
arthritis (rheumatoid arthritis, osteoarthritis, and “other”), and the ANOVA was
not significant (p > 0.05).
12. A one-way ANOVA was computed to compare the mean MCS scores of study
participants with physician-diagnosed arthritis in each of the three categories of
arthritis (rheumatoid arthritis, osteoarthritis, and “other”), and the ANOVA was
not significant (p > 0.05).
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Discussion
The main focus of this study, and the basis for the null hypothesis, was whether a
difference exists in the health-related quality of life for individuals with self-reported, physiciandiagnosed arthritis compared to the health-related quality of life for individuals without arthritis.
The PCS scores of participants reporting physician-diagnosed arthritis (66.50) were
significantly lower than the PCS scores of participants without arthritis (80.91). Based on
previous studies relating arthritis and HR-QOL, this result was expected and closely aligns with
data from studies found in the literature (van der Waal et al., 2005; Rosemann et al., 2007; Choy,
2012; Salaffi et al., 2009). Generally speaking, the symptoms of diffuse joint pain and
inflammation seen in both rheumatoid arthritis and osteoarthritis would lead to deficits in
physical functioning, which is one of the constructs the PCS score encompasses. For the most
part, these patterns held across the different demographic groups in the sample population.
The first alternative hypothesis (H2), which predicted that the PCS and MCS scores of
participants with rheumatoid arthritis would be significantly lower than the scores of participants
with other types of arthritis, was rejected through the computation of ANOVA. For one, only six
study participants reported rheumatoid arthritis. With the small amount of data available to
calculate significance in regard to H2, this result is not conclusive to the overall question of a
difference in quality of life for rheumatoid arthritis patients as compared to patients with other
types of arthritis. Studies found in the literature are split on whether or not patients with RA
have lower health-related quality of life than patients with other types of arthritis. One study
examining the differences in health-related quality of life of patients with many different chronic
diseases found RA patients scored lower than osteoarthritis patients in areas of general health
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and bodily pain, using the SF-36 questionnaire (Murillo, Almagro, Campos-Gonzalez & Cardiel,
2015) while another study found no significant difference in the health-related quality of life
between subjects with various musculoskeletal diseases, although pain and diminished healthrelated quality of life were prevalent in both RA and OA (Picavet & Hoeymans, 2003). Given
the similarity in symptoms with both RA and OA, the question of which type leads to lower
health-related quality of life scores is not easy to answer and may differ depending on the
instrument used to measure HR-QOL and the sample used. Future studies with a larger, and
more representative, population of individuals with RA should be done to definitively answer
this question.
The second alternative hypothesis (H3), which predicted that the PCS and MCS scores of
faculty and staff with arthritis would be significantly lower than the scores of students with
arthritis, was rejected through the computation of ANOVA. While some studies reported in the
literature review suggested a potential link between arthritis and lower mental health-related
quality of life scores, the data in this study showed no such relationship. In fact, ANOVA was
calculated for all participants in each demographic group and then for all arthritis participants in
each demographic group, and there were no ANOVAs showing a p-value of < 0.05,
demonstrating the lack of a significant relationship between arthritis and decreased MCS scores.
In developing the hypotheses for this study, a relationship between MCS scores and
arthritis was of particular interest because of the growing awareness of mental health in today’s
society and the growing amount of research showing the manifestation of certain mental illness
during young adulthood.
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For H3, it was predicted that faculty and staff would likely have additional domestic
responsibilities, such as taking care of children or running a household, in addition to their
responsibilities as a faculty or staff member at the university. Every group in the status variable
is different in the work and activities they are responsible for, but each has its own set of unique
concerns that could cause stress and decreased mental functioning, so the lack of significance for
MCS scores isn’t a particularly surprising result.
As previously stated, the largest proportion of participants were in the youngest age
group (18-22), and a majority of participants (65.7%) were under the age of 27, and based on
sampling techniques utilized in this study, that was expected. In comparison to the total sample,
higher proportions of older study participants reported arthritis when compared to younger study
participants. This trend holds true in other studies found in the literature, such as the Helmick
study (Helmick et al., 2008). While the Helmick study used only three age groups (and this
study used seven) the trend between increasing age and increasing prevalence of arthritis is
clearly evident in both studies.
Since rates of arthritis increased with age, it only makes sense that a negative correlation
was found between mean PCS scores and age, with PCS scores decreasing with each increasing
age group (except from 50-59 to 60+, where a slight increase was noted, possibly due to the
smaller number of participants from these age groups). The results of this study would suggest
that more participants with arthritis in the older age groups led to the decline in health-related
quality of life, which may have been the case, although with ANOVA, directionality is not
measured, only associations are, so this cannot be tested for given the conditions.
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In the absence of chronic disease, younger people typically score higher on health-related
quality of life surveys when compared to older people (Hopman, et al., 2000), so the introduction
of participants with a chronic disease, like arthritis, could create more of a difference in healthrelated quality of life scores for participants in younger age groups since they would typically
have a much higher baseline than those in older age groups would. Simply put, a chronic disease
can create more of a discrepancy in the health-related quality of life for younger individuals with
arthritis versus their counterparts without arthritis. When in their twenties, individuals are
expected to be in the best physical shape of their lives and are not supposed to suffer from joint
pain and loss of physical functioning, so a diagnosis of arthritis can greatly alter their way of life.
Additionally, the prevalence of comorbidities slightly increases each year between the
ages of 20 and 70, with the largest increases occurring after the age of 50 (Davis, Chung &
Juarez, 2011). The presence of such comorbidities is associated with decreases in physical
functioning, decreases in quality of life, and increases in depression (Davis, et al., 2011). This
provides additional support for the finding that decreasing health-related quality of life is
associated with increasing age. While the symptoms of arthritis are serious at any age, their
effects may be more noticeable among individuals at younger ages since they are less likely to
suffer from additional chronic diseases.
Additionally, the rareness of arthritis among younger individuals adds another difference
between younger and older individuals: shared experience among one’s cohort. For older
individuals, in this case 50 and over, prevalence statistics make it much more likely that an
individual suffering from arthritis will know someone else in their “circle” who also has the
disease, whereas the same prevalence statistics suggest a younger individual, in their 20s or 30s,
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will be much less likely to know someone with the disease. Many times, studies about a chronic
physical disease such as arthritis fail to examine the mental and emotional aspects of having a
lifelong disease, especially among young people in college, who are already at a higher risk of
mental illnesses such as anxiety and depression (Ibrahim, et al., 2013). While many previously
conducted quality of life studies have not found a significant association between MCS scores in
arthritis vs. non-arthritis participants, further work should be done to examine potential
associations between declining mental health and prevalence of chronic diseases (Hopman,
Harrison, Coo, Friedberg, Buchanan & VanDenKerkhof, 2009).
The fact that females had lower PCS scores than males contradicts the abundancy of
research found in the literature; females generally score lower than males in studies measuring
health-related quality of life (Hopman et al., 2000; Jenkinson, Stewart-Brown, Petersen & Paice,
1999;). This trend could be related to the higher risk of chronic autoimmune and inflammatory
diseases in females (Hopman et al., 2000). Subsequently, this risk translates into higher rates of
autoimmune diseases in females. Almost all studies reviewed during the a priori stage had more
female subjects than male subjects, due to the higher risk of arthritis among females (ArthritisRelated Statistics). This does not indicate that females have better or worse symptoms than
males do; rather it only demonstrates that more females suffer from arthritis than males. Reasons
for this gender-based difference are not fully understood, but genetics are thought to play a role
(O’Connor, 2006).
Additionally, arthritis was slightly more prevalent in males than females (16.1% of the
females in the study population reported arthritis while 20% of the males reported arthritis),
which again contradicts the findings of most other arthritis studies. Since there were many less
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male participants (13.6%) than female participants (86.1%) in the whole study, the lack of male
participants in the study was not representative of the entire UCF population and is the most
probable reason for the increase. When there are large differences in the sample sizes of two
demographic groups, small increases in the group with the smaller sample size result in larger
changes in proportion. For instance, if one fewer female had reported arthritis, the prevalence
would have decreased from 16.1% to 15.7%; if one fewer male had reported arthritis, the
prevalence would have decreased from 20.0% to 17.5%.
The population sampled from, the College of Health and Public Affairs (COHPA), has
70.5% (N=7255) females and 29.5% (N=3040) males whereas within the general population, the
two genders are relatively equal. Since the sample population had an even higher proportion of
females than the population data from COHPA, the difference in prevalence data in this study
and in studies from the literature can be attributed to the large gender gap.
This gender gap is also the most likely reason for significant difference between male and
female PCS scores; the low proportion of males in the study skewed the data toward showing an
association where one may not actually exist. With respect to gender, many previously
conducted studies had samples more representative of the general population than this study did,
so those results should be held with higher weight than the results obtained in this study.
The study’s small and unrepresentative sample may have played a role in the association
existing between mean PCS scores and ethnicity as well. It is important to note that among
previous studies conducted, differences in arthritis based on ethnicity have not typically been
found. One study comparing the severity of arthritis in Caucasian and African-American men
showed no significant findings and concluded that there were no discernable differences in the
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two groups (Mikuls et al., 2007). Similar to what was found with the gender variable, this
study’s small sample size may have contributed to the significance in among ethnicity groups
when one may not exist for the entire target population.
Since this was a study focusing on the effects of arthritis in a university population, the
question of differences in quality of life among the different status groups was an important
factor to consider, but since there are no set demographic requirements for inclusion into a status
group, differences between the groups would have to come from experiential differences related
to their roles on campus, and not biologic ones, such as age, gender, or ethnicity.
Since significant associations were found between PCS scores in the age, gender, and
ethnicity variables, it stands to reason that an association would not be found between the status
variable, since an individual of any status could belong to up to 84 different combinations of the
aforementioned three variables. The status variable erases any association found in age, gender,
or ethnicity.
As for classification, the interesting finding of extremely decreased PCS scores among
juniors stands out as a probable outlier. In trying to generalize this result to the target
population, one must question whether the small sample size of undergraduates with arthritis (n
= 22) led to a spurious correlation. While noting that junior year of college can be more
demanding than sophomore year, it is hard to find an explanation for such a drastic decrease in
PCS scores for undergraduate students one grade level apart. Moreover, the mean PCS score for
seniors is 72.63, meaning this decrease is isolated only among participants with junior
classification. The only plausible explanation for this is the age of the eight junior participants in
the study who reported arthritis. Three of the eight were above the age of 40 and as previously
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explained, increasing age was associated with decreasing PCS scores. Therefore, the
significance found with the classification variable can be attributed to the specific sample of
juniors with arthritis in our study and not a difference among juniors across all university
populations.
Perhaps the most unexpected finding in this study was the large discrepancy found
between participants reporting joint pain and participants reporting physician-diagnosed arthritis.
There are many reasons for one to experience joint pain, including relatively benign ones such as
sports injuries or normal wear and tear on the body, but arthritis is a leading cause of joint pain
and great care should be taken in the diagnosis and treatment of it. Since this study was done
through self-reporting, there is no scientific way to diagnose the cause of each participant’s joint
pain, but if the cause was an undiagnosed case of arthritis, the consequences could be serious.
Rheumatoid arthritis is a serious autoimmune disease that is systemic in nature, meaning
it affects multiple organ systems at once (Copstead & Banasik, 2013). In RA, joint pain is
caused by inflammation and destruction of joints (Copstead & Banasik, 2013). A Dutch study
examining differences in long-term RA outcomes based on length between initial symptoms and
start of disease-modifying anti-rheumatic drug (DMARD) treatment showed that earlier initiation
of medication in the disease course led to better long-term outcomes, including less joint
destruction and higher levels of remission (van der Linden et al., 2010). Following the so-called
“window of opportunity,” when initiation of treatment has the highest probability of improving
long-term outcomes, the probability of better outcomes decreases and never returns to the higher
level of probability associated with early initiation of treatment (van der Linden et al., 2010).
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Additionally, untreated rheumatoid arthritis is associated with a multitude of conditions
(Young & Koduri, 2007). In the Young study, these associated conditions, referred to as extraarticular manifestations or non-articular complications, are seen in higher proportions among
patients who have already been diagnosed with RA (Young & Koduro, 2007). In other studies,
the manifestation of certain conditions, like normochromic normocytic anemia (Wilson, HsingTing, Goodnough & Niessenson, 2004), have been correlated with decreased health-related
quality of life. More specifically, RA can lead to conditions such as atherosclerosis and
subsequent ischemic heart disease, which are aggravated by the inflammatory process prevalent
in rheumatoid arthritis (Manzi & Wasko, 2000). Both of these conditions are common risk
factors for both myocardial infarctions and cerebrovascular accidents, highlighting the
importance of treating this disease early and aggressively. When the inflammatory process
caused by RA is controlled through DMARDs, like methotrexate, and tumor necrosis factor
alpha antagonists, such as etanercept or adalimumab, the potential for many of these
complications are greatly reduced, thus improving health-related quality of life in these
individuals (Manzi & Wasko, 2000).
Other important factors to consider in the early recognition and treatment of rheumatoid
arthritis is improved the health-related quality of life individuals will experience and increased
life expectancy.
In a randomized controlled trial examining the effects of methotrexate and etanercept
treatment on the HR-QOL of patients diagnosed with RA, both drugs were shown to increase
PCS scores by between 10 and 12 points, with etanercept showing improvements more rapidly
than methotrexate (Kosinski et al., 2002). Since randomized controlled trials are analytic
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studies, causation can be inferred from the results obtained, meaning methotrexate and etanercept
lead to higher levels of quality of life in RA patients.
Another study focusing on the effects of rheumatoid arthritis on mortality found a
significant decrease in life expectancy among patients with the disease, although this decrease
can be greatly reduced through the use of DMARDs (Gabriel et al., 2003). The primary causes
of shortened life expectancy in RA patients are extra-articular manifestations and non-articular
complications, again emphasizing the importance of early detection and treatment (Gabriel et al.,
2003).
For individuals with abnormal joint pain, stiffness, or discomfort, a visit to a general
practitioner or referral to a rheumatologist would be the best course of action to either rule out
rheumatic disease or immediately begin treatment to prevent typically irreversible long-term
complications.
Despite the sampling issues faced in this study, two very important conclusions were
drawn. First, any type of physician-diagnosed arthritis is associated with lower levels of healthrelated quality of life in regard to physical and general health, per Physical Component Summary
(PCS) scores. Second, many more individuals reported symptoms of joint pain, stiffness or
discomfort than reported physician-diagnosed arthritis, suggesting the potential for a subset of
the population with undiagnosed arthritis, of which the consequences have been discussed in
great detail. This study has provided researchers with areas to focus on in future studies and has
contributed to the lack of data in the effects of arthritis on younger populations.
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Clinical Implications and Future Research
The data collected from this study is clear: individuals with arthritis are significantly
more likely to have lower quality of life scores in regard to physical health than individuals
without arthritis. This may be a relatively obvious conclusion given the symptoms of the
disease, but its significance should not be underestimated. This study did not ask participants to
include details on their treatment for arthritis, so no inferences or assumptions can be made about
the effects of possible treatment plans on lower PCS scores, but the statistics in this study, along
with other arthritis quality of life studies begs the question: is there more physicians can be doing
to improve the physical functioning of patients with arthritis? As discussed in the background
section, drug therapy is the most common method of treating both rheumatoid arthritis and
osteoarthritis, but if arthritis patients are continuing to score lower than individuals without
arthritis, perhaps drug therapy isn’t as effective as once thought. This by no means implies that
long-used drugs are ineffective at treating arthritis, but it is suggesting that researchers must
further explore options that may result in a reduction of symptoms for arthritis patients, that
would improve health-related quality of life and allow patients to live easier, and more normal
lives.
Based on the results from this study, one of the areas that future research should focus on
is exploring ways of increasing the health-related quality of life for individuals with arthritis.
The data from this study clearly shows a correlation between having arthritis and lower
PCS scores, indicating decreased quality of life. Future studies could investigate ways to
improve the quality of life for arthritis patients so they don’t have to be limited by the symptoms
the disease causes. Currently, the treatment of choice in many rheumatology clinics across the
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world is medication, and while studies have proven that disease-modifying anti-rheumatic drugs
have a positive effect on arthritis patients, many medicated arthritis patients still score lower on
quality of life scales than non-arthritis patients do (Picavet & Hoeymans, 2004). For one,
DMARDs like methotrexate can cause GI symptoms (nausea, vomiting, stomatitis), liver disease,
alopecia, and neurological side effects, all of which would contribute to lower health-related
quality of life scores (Weisman, et al., 2006). Also, the level at which medications improve
one’s quality of life plateau at a certain point, usually after about one year of treatment (Kosinski
et al., 2002), so if one still experiences symptoms of the disease at this point, there may not be
much more improvement through drug therapy.
Alternatively, newer studies on arthritis physical functioning have shown that physical
therapy can have positive effects on improving symptoms of joint pain, joint stiffness, and loss
of physical mobility, thereby improving quality of life. In a randomized controlled trial of
osteoarthritis patients, individuals treated at a physical therapy clinic showed larger
improvements on the Western Ontario and McMaster Universities Osteoarthritis Index
(WOMAC) than individuals in a control group who continued normal at home exercises (Deyle
et al., 2005). A similar effect was seen in rheumatoid arthritis patients (Forestier et al., 2009).
One study will not change years of positive results from drug therapy, but the result from
the Deyle study does suggest the addition of physical therapy could be beneficial to arthritis
patients. The research process is based on improving the status quo, especially when the status
quo leaves a lot of room for improvement. On an individual basis, rheumatologists should be
open to providing patients with the option of pursuing physical therapy treatment if they deem it
beneficial.
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Future randomized controlled trials testing the influence of physical therapy treatment on
quality of life scores should be done to further test this relationship. Since RCTs can infer
causation, this would be the most effective way of testing for such an influence.
In regard to epidemiology, future public health research must find and develop ways to
identify arthritis, particularly rheumatoid arthritis, early and implement treatment quickly and
effectively, given the serious consequences of implementing treatment as previously discussed in
this thesis. First, epidemiologists must identify the populations where RA is prevalent, perhaps
through passive surveillance, the use of available data (typically from medical or hospital
records) to monitor disease frequency and potential risk factors for said disease (Gordis, 2014).
Once initial prevalence rates are calculated among different populations, educational programs
can be targeted to those populations at particular risk for developing RA.
In a study focusing on the impressions and attitudes regarding rheumatoid arthritis,
results showed that individuals in the general public have little to no awareness of rheumatoid
arthritis and many participants in this study did not view the disease as serious (Sheppard,
Kumar, Buckley, Shaw & Raza, 2008). Additionally, many participants didn’t think they were at
risk for RA due to their younger age; many believed RA was only a disease that affects older
adults (Sheppard et al., 2008). This lack of information on behalf of many “ordinary”
individuals could directly lead to a more serious case of RA (with more joint damage and a
higher risk of comorbidities) if they were to develop the disease. If individuals are aware of both
early signs of RA and the dangerous implications of waiting to seek treatment, they should be
more likely to visit their primary care physician, who can then refer them to a rheumatologist for
more specialized treatment.
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Such preconceived notions and attitudes about other chronic diseases could lead to
similar outcomes, so epidemiologists and public health officials should be aware of this problem
and must develop ways to close the knowledge gap and protect potential RA patients from their
own attitudes and beliefs.
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Limitations
Sampling
The most significant challenge faced in the planning and conduction of this study was
how to effectively sample. Given strict time constraints and the fact that this study was done for
the completion of an undergraduate thesis meant that direct patient contact was not an option, so
a self-reported questionnaire was used. The initial plan was to distribute the questionnaire via a
campus-wide email to the entire student body, faculty and staff at the University of Central
Florida, with the possibility of reaching over 60,000 potential participants; however, an
agreement was not able to be made between the researchers and the various campus outlets
responsible for the dissemination of such email messages, so the questionnaire was sent to all
students (undergraduate and graduate/professional), faculty, and staff within the College of
Health and Public Affairs (COHPA), which was made up of just over 10,000 potential
respondents. This led to an inevitable selection bias, since a study designed to sample from the
entire UCF population was limited to participants from one subset of the university. Perhaps the
largest source of selection bias came from the unequal gender proportions within COHPA;
student-wise, 70.5% of COHPA is made up of females and 29.5% of males. Population data was
not available for staff and faculty, but since students made up most of the potential sample, the
gender of students has the largest effect on the results. Further analysis of the gender gap can be
found in the “Gender and HR-QOL” section.
Use of Self-Reported Data
The use of self-reported surveys or questionnaires always introduces the potential for
response biases and misclassification biases. For one, out of over 10,000 questionnaires sent out,
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only 333 responses were received, meaning that over 95% of potential participants failed to
respond. While it is likely that most people who didn’t respond didn’t do so because of the
subject of the study, but rather didn’t see the email or never read it, a nonresponse bias exists.
Many previous studies utilizing a self-reporting mechanism of obtaining data have found
a social desirability bias affecting the results (van de Mortel, 2008). Without a researcher
directly facilitating the data collection process, participants in self-reported studies tend to
answer questions that project themselves in a more favorable light (van de Mortel, 2008).
Reasons for this are not understood, especially since all responses in this study (and in most selfreported studies) were anonymous, but nevertheless, it is still a weakness of self-reported data
and may have diminished this study’s external validity.
Finally, there is no way of verifying the answers of questions in the screener survey, used
to classify participants, which could have created a misclassification bias in the results. The
main point of comparison in this study was the presence (or absence) of physician-diagnosed
arthritis and any error in the self-reported answers of this question would not be accurate and
negatively affected the study results.
Any limitations encountered in the study affect the ability with which its findings can be
generalized to the target population (students, faculty, and staff at universities around the United
States). When generalizability is diminished, the power a study has to speak about associations
in a larger context is affected. These issues aren’t as serious in cross-sectional studies as they
would be in experimental studies where causality can be inferred. Many of the associations
found in this study have been found in other, very reliable studies and the conclusions drawn
from this study’s results are ones that have been seen in the literature.
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Appendix A: Screener Survey
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Screener Survey
1. Are you 18 years of age or older?
a. Yes
b. No (end survey)
2. What is your age range?
a. 18-22
b. 23-27
c. 28-32
d. 33-39
e. 40-49
f. 50-59
g. ≥ 60
3. What is your gender?
a. Male
b. Female
c. Other
4. What is your ethnicity?
a. American Indian or Alaska Native
b. Asian
c. Black or Native American
d. Native Hawaiian or Other Pacific Islander
e. White
f. Hispanic or Latino
g. Other
5. What is your status at UCF (mark all that apply)?
a. Faculty
b. Staff
c. Graduate Student
d. Undergraduate Student
e. Non-degree Seeking Student
6. What is your classification?
a. Freshman (1-30 credit hours)
b. Sophomore (31-60 credit hours)
c. Junior (61-90 credit hours)
d. Senior (91-120 credit hours)
e. Senior (120+ credit hours)
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7. During the past few months, have you had any symptoms of pain, aching, or stiffness in
or around a joint?
a. Yes
b. No
c. Don’t know
8. Have you ever been told by a doctor or other health professional that you have some form
of arthritis?
a. Yes (go to question 9)
b. No (go to the SF-36 survey)
c. Don’t know
9. What type of arthritis were you diagnosed with?
a. Rheumatoid Arthritis
b. Osteoarthritis
c. Other (please specify)
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Appendix B: 36-Item Short Form Survey Instrument (SF-36)
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36-Item Short Form Survey Instrument (SF-36)
1. In general, would you say your health is:
a. 1 - Excellent
b. 2 - Very good
c. 3 - Good
d. 4 - Fair
e. 5 - Poor
2. Compared to one year ago, how would you rate your health in general now?
a. 1 - Much better now than one year ago
b. 2 - Somewhat better now than one year ago
c. 3 - About the same
d. 4 - Somewhat worse now than one year ago
e. 5 - Much worse now than one year ago
The following items are about activities you might do during a typical day. Does your health
now limit you in these activities? If so, how much?
3. Vigorous activities, such as running, lifting heavy objects, participating in strenuous
sports
a. 1 - Yes, limited a lot
b. 2 - Yes, limited a little
c. 3 - No, not limited at all
4. Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or
playing golf
a. 1 - Yes, limited a lot
b. 2 - Yes, limited a little
c. 3 - No, not limited at all
5. Lifting or carrying groceries
a. 1 - Yes, limited a lot
b. 2 - Yes, limited a little
c. 3 - No, not limited at all
6. Climbing several flights of stairs
a. 1 - Yes, limited a lot
b. 2 - Yes, limited a little
c. 3 - No, not limited at all
7. Climbing one flight of stairs
a. 1 - Yes, limited a lot
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b. 2 - Yes, limited a little
c. 3 - No, not limited at all
8. Bending, kneeling, or stooping
a. 1 - Yes, limited a lot
b. 2 - Yes, limited a little
c. 3 - No, not limited at all
9. Walking more than a mile
a. 1 - Yes, limited a lot
b. 2 - Yes, limited a little
c. 3 - No, not limited at all
10. Walking several blocks
a. 1 - Yes, limited a lot
b. 2 - Yes, limited a little
c. 3 - No, not limited at all
11. Walking one block
a. 1 - Yes, limited a lot
b. 2 - Yes, limited a little
c. 3 - No, not limited at all
12. Bathing or dressing yourself
a. 1 - Yes, limited a lot
b. 2 - Yes, limited a little
c. 3 - No, not limited at all
During the past 4 weeks, have you had any of the following problems with your work or other
regular daily activities as a result of your physical health?
13. Cut down the amount of time you spent on work or other activities
a. 1 - Yes
b. 2 - No
14. Accomplished less than you would like
a. 1 - Yes
b. 2 - No
15. Were limited in the kind of work or other activities
a. 1 - Yes
b. 2 - No
16. Had difficulty performing the work or other activities (for example, it took extra effort)
a. 1 - Yes
b. 2 - No
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During the past 4 weeks, have you had any of the following problems with your work or other
regular daily activities as a result of any emotional problems (such as feeling depressed or
anxious)?
17. Cut down the amount of time you spent on work or other activities
a. 1 - Yes
b. 2 - No
18. Accomplished less than you would like
a. 1 - Yes
b. 2 - No
19. Didn’t do work or other activities as carefully as usual
a. 1 - Yes
b. 2 - No
20. During the past 4 weeks, to what extent has your physical health or emotional problems
interfered with your normal social activities with family, friends, neighbors, or groups?
a. 1 - Not at all
b. 2 - Slightly
c. 3 - Moderately
d. 4 - Quite a bit
e. 5 - Extremely
21. How much bodily pain have you had during the past 4 weeks?
a. 1 - None
b. 2 - Very mild
c. 3 - Mild
d. 4 - Moderate
e. 5 - Severe
f. 6 - Very severe
22. During the past 4 weeks, how much did pain interfere with your normal work (including
both work outside the home and housework)?
a. 1 - Not at all
b. 2 - A little bit
c. 3 - Moderately
d. 4 - Quite a bit
e. 5 - Extremely
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These questions are about how you feel and how things have been with you during the past 4
weeks. For each question, please give the one answer that comes closest to the way you have
been feeling.
How much of the time during the past 4 weeks…
23. Did you feel full of pep?
a. 1 - All of the time
b. 2 - Most of the time
c. 3 - A good bit of the time
d. 4 - Some of the time
e. 5 - A little of the time
f. 6 - None of the time
24. Have you been a very nervous person?
a. 1 - All of the time
b. 2 - Most of the time
c. 3 - A good bit of the time
d. 4 - Some of the time
e. 5 - A little of the time
f. 6 - None of the time
25. Have you felt so down in the dumps that nothing could cheer you up?
a. 1 - All of the time
b. 2 - Most of the time
c. 3 - A good bit of the time
d. 4 - Some of the time
e. 5 - A little of the time
f. 6 - None of the time
26. Have you felt calm and peaceful?
a. 1 - All of the time
b. 2 - Most of the time
c. 3 - A good bit of the time
d. 4 - Some of the time
e. 5 - A little of the time
f. 6 - None of the time
27. Did you have a lot of energy?
a. 1 - All of the time
b. 2 - Most of the time
c. 3 - A good bit of the time
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d. 4 - Some of the time
e. 5 - A little of the time
f. 6 - None of the time
28. Have you felt downhearted and blue?
a. 1 - All of the time
b. 2 - Most of the time
c. 3 - A good bit of the time
d. 4 - Some of the time
e. 5 - A little of the time
f. 6 - None of the time
29. Did you feel worn out?
a. 1 - All of the time
b. 2 - Most of the time
c. 3 - A good bit of the time
d. 4 - Some of the time
e. 5 - A little of the time
f. 6 - None of the time
30. Have you been a happy person?
a. 1 - All of the time
b. 2 - Most of the time
c. 3 - A good bit of the time
d. 4 - Some of the time
e. 5 - A little of the time
f. 6 - None of the time
31. Did you feel tired?
a. 1 - All of the time
b. 2 - Most of the time
c. 3 - A good bit of the time
d. 4 - Some of the time
e. 5 - A little of the time
f. 6 - None of the time
32. During the past 4 weeks, how much of the time has your physical health or emotional
problems interfered with your social activities (like visiting with friends, relatives, etc.)?
a. 1 - All of the time
b. 2 - Most of the time
c. 3 - Some of the time
d. 4 - A little of the time
e. 5 - None of the time
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How TRUE or FALSE is each of the following statements for you.
33. I seem to get sick a little easier than other people
a. 1 - Definitely true
b. 2 - Mostly true
c. 3 - Don’t know
d. 4 - Mostly false
e. 5 - Definitely false
34. I am as healthy as anybody I know
a. 1 - Definitely true
b. 2 - Mostly true
c. 3 - Don’t know
d. 4 - Mostly false
e. 5 - Definitely false
35. I expect my health to get worse
a. 1 - Definitely true
b. 2 - Mostly true
c. 3 - Don’t know
d. 4 - Mostly false
e. 5 - Definitely false
36. My health is excellent
a. 1 - Definitely true
b. 2 - Mostly true
c. 3 - Don’t know
d. 4 - Mostly false
e. 5 - Definitely false
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